CVS Argues For Denial Of Preliminary Injunction Motion In Trade Secret Suit

Mealey's (November 21, 2018, 11:44 AM EST) -- TAMPA, Fla. — Arguing that a third-party administrator of the U.S. government’s 340B drug pricing program’s motion for preliminary injunction in a trade secret misappropriation lawsuit is “late, unsupported by fact and contrary to law,” defendants CVS Pharmacy Inc. and subsidiary Wellpartner LLC on Nov. 19 asked a federal judge in Florida to deny the motion in its entirety (RxStrategies Inc. v. CVS Pharmacy Inc., et al., No. 18-1087, M.D. Fla.)....